找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Chemosensitivity Testing in Oncology; Uwe Reinhold,Wolfgang Tilgen Conference proceedings 2003 Springer-Verlag Berlin Heidelberg 2003 brea

[复制链接]
楼主: 涌出
发表于 2025-3-27 00:18:04 | 显示全部楼层
Development of a New In Vitro Chemosensitivity Test Using Collagen Gel Droplet Embedded Culture and er drugs can be selected for each patient using the screening methods. In such a background, we developed a new anticancer-drug sensitivity testing method that overcame several defects in the existing method, which is the collagen gel droplet embedded culture drug sensitivity test (CD-DST) and satis
发表于 2025-3-27 03:05:02 | 显示全部楼层
In Vitro Chemosensitivity Testing of Hematological Cancer Patients: Detection of Ornithine Decarboxyer research and treatment. Early attempts to develop individualized chemotherapy were based on clonogenic assays. These attempts failed because of low plating efficiencies. Nonclonogenic assays, such as the MMT test or ATP determinations, are based on metabolic activities and do not reflect the abil
发表于 2025-3-27 07:52:29 | 显示全部楼层
The Chemosensitivity Profile of Retinoblastomaed in retinoblastoma as adjuvant therapy to prevent the growth of metastases and to treat metastatic disease once this has become clinically apparent. Current regimens are based on empirical drug combinations, and few clinical trials have been conducted because of the rarity of this tumour. Chemosen
发表于 2025-3-27 13:27:39 | 显示全部楼层
发表于 2025-3-27 16:50:18 | 显示全部楼层
Human Melanoma: Drug Resistancece of melanoma cells to systemic treatment with antineoplastic agents. The reasons for the chemoresistant phenotype are currently unknown. The relevance of well-analyzed drug resistance mechanisms in melanoma such as intracellular and extracellular transport, drug resistance by induction of certain
发表于 2025-3-27 18:38:19 | 显示全部楼层
发表于 2025-3-27 23:49:39 | 显示全部楼层
发表于 2025-3-28 02:31:26 | 显示全部楼层
Assay-Assisted Treatment Selection for Women with Breast or Ovarian Cancereir lives. The use of these agents is based on demonstrated benefit in large randomized clinical trials, and the clinical activity of these chemotherapy regimens is initially high, with 60%–70% of patients responding. Unfortunately, their benefit in the second-line setting is often limited, with les
发表于 2025-3-28 09:08:08 | 显示全部楼层
发表于 2025-3-28 14:26:13 | 显示全部楼层
Treosulfan in the Treatment of Metastatic Melanoma: From Chemosensitivity Testing to Clinical Trialsotential new drugs in this disease. To examine the effects of the bifunctional alkylating cytostatic treosulfan, an in vitro microplate ATP bioluminescence assay (ATP-TCA) was used. Five highly chemoresistant melanoma cell lines and melanoma cells freshly isolated from metastases surgically resected
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-28 07:18
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表